Chiome Bioscience Inc. [4583.T]
TOKYO, May 25 (Pulse News Wire) – Chiome Bioscience Inc. (4583.T) reported the large-scale exercise of its 23rd series warrants (with adjusted exercise price clause) from May 1 to May 22, 2026.
During this period, a total of 1,616,600 new shares were issued through the exercise of 16,166 warrants, which represent 11.88% of the total warrants issued. As of the end of April, there were 72,045 unexercised warrants remaining, which decreased to 55,879 as of the latest report.
The warrants were exercised on eight trading days, each issued entirely as new shares with no treasury shares transferred. New shares issued were 143,400 on May 1, 125,400 on May 8, 164,500 on May 13, 109,900 on May 14, 139,600 on May 15, 189,500 on May 19, 328,800 on May 21, and 415,500 on May 22, for a total of 1,616,600 shares.
As of the end of the previous month, the outstanding ordinary shares stood at 74,459,300, including 22,819 treasury shares.
🟢 Confidence: High AI-translated content.